UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma

Journal of clinical oncology, 2015-09, Vol.33 (25), p.2803-2811

2015

Volltextzugriff (PDF)

AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma

Journal of clinical oncology, 2019-05, Vol.37 (14), p.1188-1199

2019

Volltextzugriff (PDF)

Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study

Journal of clinical oncology, 2019-10, Vol.37 (30), p.2722-2729

2019

Volltextzugriff (PDF)

Blocking autophagy prevents bortezomib-induced NF-κB activation by reducing I-κBα degradation in lymphoma cells

PloS one, 2012-02, Vol.7 (2), p.e32584-e32584

2012

Volltextzugriff (PDF)

Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia

Current cancer drug targets, 2016-10, Vol.16 (8), p.689-700

2016

Volltextzugriff (PDF)

Expression of FOXP3, CD68, and CD20 at Diagnosis in the Microenvironment of Classical Hodgkin Lymphoma Is Predictive of Outcome

Journal of clinical oncology, 2013-01, Vol.31 (2), p.256-262

2013

Volltextzugriff (PDF)

HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era

Journal of clinical oncology, 2012-11, Vol.30 (33), p.4111-4116

2012

Volltextzugriff (PDF)

Follicular Lymphoma Cells Induce Changes in T-Cell Gene Expression and Function: Potential Impact on Survival and Risk of Transformation

Journal of clinical oncology, 2013-07, Vol.31 (21), p.2654-2661

2013

Volltextzugriff (PDF)

High Throughput Sequencing Analysis of the Immunoglobulin Heavy Chain Gene from Flow-Sorted B Cell Sub-Populations Define the Dynamics of Follicular Lymphoma Clonal Evolution

PloS one, 2015-09, Vol.10 (9), p.e0134833

2015

Volltextzugriff (PDF)

Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Study 9712

Journal of clinical oncology, 2011-04, Vol.29 (10), p.1349-1355

2011

Volltextzugriff (PDF)

Comprehensive Assessment of Genetic and Molecular Features Predicting Outcome in Patients With Chronic Lymphocytic Leukemia: Results From the US Intergroup Phase III Trial E2997

Journal of clinical oncology, 2007-03, Vol.25 (7), p.799-804

2007

Volltextzugriff (PDF)

Quantitative DNA Methylation Analysis Identifies a Single CpG Dinucleotide Important for ZAP-70 Expression and Predictive of Prognosis in Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2012-07, Vol.30 (20), p.2483-2491

2012

Volltextzugriff (PDF)

Immune dysfunction in chronic lymphocytic leukemia: the role for immunotherapy

Current pharmaceutical design, 2012-08, Vol.18 (23), p.3389-3398

2012

Volltextzugriff (PDF)

Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma

Cell death & disease, 2019-04, Vol.10 (5), p.330-330, Article 330

2019

Volltextzugriff (PDF)

Rituximab Plus Chlorambucil As First-Line Treatment for Chronic Lymphocytic Leukemia: Final Analysis of an Open-Label Phase II Study

Journal of clinical oncology, 2014-04, Vol.32 (12), p.1236-1241

2014

Volltextzugriff (PDF)

Myeloablative Therapy With Autologous Bone Marrow Transplantation for Follicular Lymphoma at the Time of Second or Subsequent Remission: Long-Term Follow-Up

Journal of clinical oncology, 2007-06, Vol.25 (18), p.2554-2559

2007

Volltextzugriff (PDF)

Select High-Risk Genetic Features Predict Earlier Progression Following Chemoimmunotherapy With Fludarabine and Rituximab in Chronic Lymphocytic Leukemia: Justification for Risk-Adapted Therapy

Journal of clinical oncology, 2006-01, Vol.24 (3), p.437-443

2006

Volltextzugriff (PDF)

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Crohn's Disease: Current Status and Future Directions. A Review on Behalf of the EBMT Autoimmune Diseases Working Party and the Autologous Stem Cell Transplantation In Refractory CD-Low Intensity Therapy Evaluation Study Investigators

Frontiers in immunology, 2018-04, Vol.9, p.646-646

2018

Volltextzugriff (PDF)

Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity

PloS one, 2013-10, Vol.8 (10), p.e76781-e76781

2013

Volltextzugriff (PDF)

Number of CD4+ Cells and Location of Forkhead Box Protein P3–Positive Cells in Diagnostic Follicular Lymphoma Tissue Microarrays Correlates With Outcome

Journal of clinical oncology, 2006-11, Vol.24 (31), p.5052-5059

2006

Volltextzugriff (PDF)

Implications of the tumor microenvironment on survival and disease response in follicular lymphoma

Current opinion in oncology, 2010-09, Vol.22 (5), p.424-430

Gribben, John G

2010

Volltextzugriff (PDF)

Fertility and sexual function in long‐term survivors of haematological malignancy: using patient‐reported outcome measures to assess a neglected area of need in the late effects clinic

British journal of haematology, 2014-02, Vol.164 (4), p.526-535

2014

Volltextzugriff (PDF)

Development of a physiologically based pharmacokinetic model of actinomycin D in children with cancer

British journal of clinical pharmacology, 2016-05, Vol.81 (5), p.989-998

2016

Volltextzugriff (PDF)

5-Year Survival in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia in a Randomized, Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen

Journal of clinical oncology, 2009-11, Vol.27 (31), p.5208-5212

2009

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Publikationsformmagazinearticle

KollektionIngentaConnect Journals

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(54)

Sprache

Englisch
(54)

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(41)
Oncology
(27)
Female
(26)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Male
(23)
Adult
(21)
Middle Aged
(21)
Tumors
(17)
Hematologic And Hematopoietic Diseases
(16)
Aged
(15)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(14)
Animals
(12)
Treatment Outcome
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Aged, 80 And Over
(9)
Mice
(8)
Original Reports
(8)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma

AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma

Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study

Blocking autophagy prevents bortezomib-induced NF-κB activation by reducing I-κBα degradation in lymphoma cells

Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia

Expression of FOXP3, CD68, and CD20 at Diagnosis in the Microenvironment of Classical Hodgkin Lymphoma Is Predictive of Outcome

HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era

Lack of reproducibility of histopathological features in MYC‐rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortium

Follicular Lymphoma Cells Induce Changes in T-Cell Gene Expression and Function: Potential Impact on Survival and Risk of Transformation

High Throughput Sequencing Analysis of the Immunoglobulin Heavy Chain Gene from Flow-Sorted B Cell Sub-Populations Define the Dynamics of Follicular Lymphoma Clonal Evolution

Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Study 9712

Comprehensive Assessment of Genetic and Molecular Features Predicting Outcome in Patients With Chronic Lymphocytic Leukemia: Results From the US Intergroup Phase III Trial E2997

Quantitative DNA Methylation Analysis Identifies a Single CpG Dinucleotide Important for ZAP-70 Expression and Predictive of Prognosis in Chronic Lymphocytic Leukemia

Immune dysfunction in chronic lymphocytic leukemia: the role for immunotherapy

Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma

Rituximab Plus Chlorambucil As First-Line Treatment for Chronic Lymphocytic Leukemia: Final Analysis of an Open-Label Phase II Study

Myeloablative Therapy With Autologous Bone Marrow Transplantation for Follicular Lymphoma at the Time of Second or Subsequent Remission: Long-Term Follow-Up

Select High-Risk Genetic Features Predict Earlier Progression Following Chemoimmunotherapy With Fludarabine and Rituximab in Chronic Lymphocytic Leukemia: Justification for Risk-Adapted Therapy

Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity

Number of CD4+ Cells and Location of Forkhead Box Protein P3–Positive Cells in Diagnostic Follicular Lymphoma Tissue Microarrays Correlates With Outcome

Implications of the tumor microenvironment on survival and disease response in follicular lymphoma

Fertility and sexual function in long‐term survivors of haematological malignancy: using patient‐reported outcome measures to assess a neglected area of need in the late effects clinic

Development of a physiologically based pharmacokinetic model of actinomycin D in children with cancer

5-Year Survival in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia in a Randomized, Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen

Aktive Filter

Suchergebnisse filtern